← All diseases
Muscles and connective tissue
Duchenne muscular dystrophy
Would you like to receive a message when there is new research on Duchenne muscular dystrophy? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above every publication you'll see one sentence explaining what was studied — and you'll get notified as soon as there's new research on Duchenne muscular dystrophy. View what Premium costs.
Publications and studies (1745)
- Evaluation of the redox alteration in Duchenne muscular dystrophy model mice using in vivo DNP-MRI. (2024/12/05) ♡
- Frequency of Delayed Puberty in Boys with Contemporary Management of Duchenne Muscular Dystrophy. (2024/12/04) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Treatment of giant fecalith colonic obstruction in a patient with Duchenne muscular dystrophy using endoscopic injection of hydrogen peroxide: a case report and literature review. (2024/12/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Review of Muscle Relaxants in Anesthesia in Patients with Neuromuscular Disorders Including Guillain-Barré Syndrome, Myasthenia Gravis, Duchenne Muscular Dystrophy, Charcot-Marie-Tooth Disease, and Inflammatory Myopathies. (2024/12/02) ♡
- Anti-necroptotic effects of human Wharton's jelly-derived mesenchymal stem cells in skeletal muscle cell death model via secretion of GRO-α. (2024/12/02) ♡
- Pelvic obliquity, trunk control, and motor function: an exploratory study in a non-ambulatory Duchenne muscular dystrophy cohort. (2024/12/02) ♡
- Effects of a Ketogenic Diet on the Assessment of Biochemical and Clinical Parameters in Duchenne Muscular Dystrophy: A Preclinical Investigation. (2024/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prevalence of Neutralizing Antibodies Against AAV Serotypes 2 and 9 in Healthy Participants from Multiple Centers Across China and Patients with DMD/BMD. (2024/12/01) ♡
- Long-Term Survival and Myocardial Function Following Systemic Delivery of Delandistrogene Moxeparvovec in DMD(MDX) Rats. (2024/12/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. No Time to Relax: Expanding CMR Utility in Duchene Muscular Dystrophy. (2024/12/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Boys With Duchenne Muscular Dystrophy Have Diastolic Dysfunction Based on CMR. (2024/12/01) ♡
- Genomic insights into Duchene muscular dystrophy: Analysis of 1250 patients reveals 30% novel genetic patterns and 6 novel variants. (2024/12/01) ♡
- Muscle Pathology Associated With Cardiac Function in Duchenne Muscular Dystrophy. (2024/12/01) ♡
- Impact of distinct dystrophin gene mutations on behavioral phenotypes of Duchenne muscular dystrophy. (2024/12/01) ♡
- Safety and effectiveness of ataluren in patients with Duchenne muscular dystrophy: single-center experience from Saudi Arabia. (2024/12/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Effect of Electroacupuncture on Disease Progression in Duchenne Muscular Dystrophy: A Case Report. (2024/12/01) ♡
- Quality of life and caregiving burden associated with parenting a person with Duchenne/Becker muscular dystrophy in Poland. (2024/11/30) ♡
- Identification of disease-specific extracellular vesicle-associated plasma protein biomarkers for Duchenne Muscular Dystrophy and Facioscapulohumeral Muscular Dystrophy. (2024/11/30) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. 46,XY disorders of sex development and muscular dystrophy caused by Xp21 duplication: a case report and literature review. (2024/11/30) ♡
- Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpoint. (2024/11/29) ♡
- Golodirsen restores DMD transcript imbalance in Duchenne Muscular Dystrophy patient muscle cells. (2024/11/29) ♡
- Clinical Profile and Pulmonary Function of Pediatric Patients with Duchenne Muscular Dystrophy at a Tertiary Government Hospital. (2024/11/29) ♡
- Expanding the Molecular Genetic Landscape of Dystrophinopathies and Associated Phenotypes. (2024/11/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Poor bone health in Duchenne muscular dystrophy: a multifactorial problem beyond corticosteroids and loss of ambulation. (2024/11/28) ♡
- Research hotspots and trends for Duchenne muscular dystrophy: a machine learning bibliometric analysis from 2004 to 2023. (2024/11/28) ♡
- MRI-Based Circumferential Strain in Boys with Early Duchenne Muscular Dystrophy Cardiomyopathy. (2024/11/27) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Neuromuscular diseases: genomics-driven advances. (2024/11/26) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Methylphenidate treatment of a Chinese boy with Becker muscular dystrophy combined with attention deficit hyperactivity disorder: a case report. (2024/11/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. An Updated Analysis of Exon-Skipping Applicability for Duchenne Muscular Dystrophy Using the UMD-DMD Database. (2024/11/20) ♡
- Identification of reference microRNAs in skeletal muscle of a canine model of Duchenne muscular dystrophy. (2024/11/20) ♡
- DMD mutations in pediatric patients with phenotypes of Duchenne/Becker muscular dystrophy. (2024/11/15) ♡
- Duchenne muscular dystrophy patients diagnosed at the asymptomatic stage: What are the benefits of early diagnosis? (2024/11/14) ♡
- Lipin1 as a therapeutic target for respiratory insufficiency of duchenne muscular dystrophy. (2024/11/12) ♡
- Epigenetic control of myogenic identity of human muscle stem cells in Duchenne muscular dystrophy. (2024/11/08) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Duchenne Muscular Dystrophy in Two Half-Brothers Due to Inherited 306 Kb Inverted Insertion of 10p15.1 into Intron 44 of the Dp427m Transcript of the DMD Gene. (2024/11/06) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. In Vitro Gene Therapy Using Human iPS-Derived Mesoangioblast-Like Cells (HIDEMs) Combined with Microdystrophin (μDys) Expression as the New Strategy for Duchenne Muscular Dystrophy (DMD) Experimental Treatment. (2024/11/05) ♡
- Long-term course of gastrostomy nutritional management in patients with Duchenne muscular dystrophy: A retrospective cohort study. (2024/11/01) ♡
- Gross motor delays in infants and young boys with Duchenne muscular dystrophy. (2024/11/01) ♡
- An Exoskeleton Design and Numerical Characterization for Children with Duchenne Muscular Dystrophy. (2024/10/26) ♡
- Utilization of Multi-Parametric Quantitative Magnetic Resonance Imaging in the Early Diagnosis of Duchenne Muscular Dystrophy. (2024/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial for "Utilization of Multi-Parametric Quantitative Magnetic Resonance Imaging in the Early Diagnosis of Duchenne Muscular Dystrophy". (2024/10/01) ♡
- 274th ENMC international workshop: recommendations for optimizing bone strength in neuromuscular disorders. Hoofddorp, The Netherlands, 19-21 January 2024. (2024/10/01) ♡
- Mitohormesis during advanced stages of Duchenne muscular dystrophy reveals a redox-sensitive creatine pathway that can be enhanced by the mitochondrial-targeting peptide SBT-20. (2024/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Reductions in functional muscle mass and ability to ambulate in Duchenne muscular dystrophy from ages 4 to 24 years. (2024/10/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Effect of Oral Zinc Supplementation on Phase Angle and Bioelectrical Impedance Vector Analysis in Duchenne Muscular Dystrophy: A Non-Randomized Clinical Trial. (2024/09/29) ♡
- Effect of Zinc Supplementation on Body Composition of Duchenne Muscular Dystrophy Patients: A Quasi-Experimental Study. (2024/09/18) ♡
- Sexual health and fertility in Duchenne muscular dystrophy—An exploratory study. (2024/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transition and management of patients with Duchenne Muscular Dystrophy: a narrative review based on Italian experts' opinion and real-world experience. (2024/09/01) ♡
- Comprehensive analysis of 2097 patients with dystrophinopathy based on a database from 2011 to 2021. (2024/08/24) ♡
- Unveiling the Respiratory Muscle Strength in Duchenne Muscular Dystrophy: The Impact of Nutrition and Thoracic Deformities, Beyond Spirometry. (2024/08/15) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.